Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2022 financial results

16 Feb 2023 13:02 CET

Oslo, Norway, 16 February 2023: Photocure ASA (Photocure, PHO: OSE) will
announce the fourth quarter and preliminary full year 2022 financial results on
Thursday 23 February 2023 at 08:00 CET and will present a live webcast at 14:00
CET the same day.

The quarterly report and presentation will be published at 08:00 CET and will be
publicly available at www.photocure.com.

The investor presentation will be streamed live and be hosted by Daniel
Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and
questions can be submitted throughout the event. The presentation is scheduled
to conclude at 14:45 CET.

The streaming event is available through
https://channel.royalcast.com/landingpage/hegnarmedia/20230223_8/.

For further information, please contact:

Photocure
Erik Dahl
CFO
Tel: +47 45055000
Email: ed@photocure.com

David Moskowitz
Vice President, Investor Relations
Tel: +1 202 280 0888
Email: david.moskowitz@photocure.com

Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway) Tel: +47 91540000
Email: geir.bjorlo@corpcom.no

About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com, www.cysview.com

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.

More information:
Access the news on Oslo Bors NewsWeb site